LiFE | Literature for ENYGO
暂无分享,去创建一个
[1] A. Schott,et al. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone. , 2016, American journal of obstetrics and gynecology.
[2] R. Berkowitz,et al. The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. , 2016, Gynecologic oncology.
[3] Y. Zhang,et al. Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery , 2016, PloS one.
[4] M. Picchio,et al. [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective. , 2016, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[5] M. Saidani,et al. Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[6] L. Sunde,et al. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group , 2016, Acta oncologica.
[7] T. Nagao,et al. Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells. , 2016, Oncology reports.
[8] E. Cavalier,et al. Persistent low levels of serum hCG due to heterophilic mouse antibodies: an unrecognized pitfall in the diagnosis of trophoblastic disease , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[9] N. Bickell,et al. Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995–2008 , 2016, Obstetrics and gynecology.
[10] F. Sweep,et al. Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. , 2016, Gynecologic oncology.
[11] R. Angioli,et al. The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program , 2016, Tumor Biology.
[12] A. Fyles,et al. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[13] Rossella Di Pierro,et al. [Gestational Trophoblastic Disease: psychological impact and the role of defence mechanisms during illness and follow-up]. , 2015, Recenti progressi in medicina.
[14] L. Elit,et al. Recommendations for Follow-up Care for Gynecologic Cancer Survivors. , 2015, Obstetrics and gynecology.
[15] H. Matsui,et al. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia. , 2015, Gynecologic oncology.
[16] Yinfeng Wang,et al. Medical termination of a partial hydatidiform mole and coexisting fetus during the second trimester: A case report. , 2015, Oncology letters.
[17] R. Francisco,et al. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? , 2015, Clinics.
[18] Mei Peng,et al. Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm , 2015, PloS one.
[19] A. Ben-Haroush,et al. Endometrial Cancer Surgery for Elderly Women—The Early Postoperative Period , 2015, International Journal of Gynecologic Cancer.
[20] Kathy L. MacLaughlin,et al. Surveillance and Care of the Gynecologic Cancer Survivor , 2015, Journal of women's health.
[21] E. Ko,et al. Adjuvant Treatment and Clinical Trials in Elderly Patients With Endometrial Cancer: A Time for Change? , 2015, International Journal of Gynecologic Cancer.
[22] Yuxin Tang,et al. An invasive mole with bilateral kidney metastases: A case report , 2015, Oncology letters.
[23] Eva Pagano,et al. Economic Considerations on the Follow-Up Practice in Gynecologic Cancers: Few Lights and Many Shadows From a Literature Review , 2015, International Journal of Gynecologic Cancer.
[24] O. Ortmann,et al. Invasive mole in a perimenopausal woman: a case report and systematic review , 2014, Archives of Gynecology and Obstetrics.
[25] W. Cheung,et al. Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologists , 2015, Journal of Cancer Survivorship.
[26] C. Fournier,et al. Occult Invasive Cervical Cancer Found After Inadvertent Simple Hysterectomy: Is the Ideal Management: Systematic Parametrectomy With or Without Radiotherapy or Radiotherapy Only? , 2015, Annals of Surgical Oncology.
[27] J. Sheeder,et al. Comparative Outcomes in Older and Younger Women Undergoing Laparotomy or Robotic Surgical Staging for Endometrial Cancer , 2014 .
[28] T. Lawrie,et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. , 2012, The Cochrane database of systematic reviews.